Reproducibility of published model-based cancer drug cost-effectiveness analyses: a study protocol for a cross-sectional analysis

Introduction Model-based cost-effectiveness analysis (CEA) of pharmaceuticals informs reimbursement and pricing in many healthcare systems, and it is essential that CEA evidence is valid and reliable. Several studies have reported lacking transparency in CEA studies. In this study protocol, we descr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mikael Svensson, Martin Henriksson, Naimi Johansson, Jonathan Siverskog
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/6/e096719.full
Tags: Add Tag
No Tags, Be the first to tag this record!